CytoDyn Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CytoDyn Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • CytoDyn Inc. Net Income (Loss) Attributable to Parent for the quarter ending August 31, 2024 was $19.2M.
  • CytoDyn Inc. Net Income (Loss) Attributable to Parent for the twelve months ending August 31, 2024 was -$19M, a 73% increase year-over-year.
  • CytoDyn Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$49.8M, a 37.6% increase from 2022.
  • CytoDyn Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$79.8M, a 62.1% increase from 2021.
  • CytoDyn Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$211M, a 19.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19M $19.2M +$30.8M Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q2 2024 -$49.8M -$16.8M +$1.85M +9.92% Mar 1, 2024 May 31, 2024 10-K 2024-08-15
Q1 2024 -$51.7M -$11.9M +$1.78M +13% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 -$53.5M -$9.56M +$16.9M +63.9% Sep 1, 2023 Nov 30, 2023 10-Q 2024-04-15
Q3 2023 -$70.4M -$11.6M +$9.42M +44.9% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
Q2 2023 -$79.8M -$18.6M +$65.5M +77.8% Mar 1, 2023 May 31, 2023 10-K 2024-08-15
Q1 2023 -$145M -$13.7M +$27.6M +66.8% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 -$173M -$26.5M +$13.6M +33.9% Sep 1, 2022 Nov 30, 2022 10-Q 2024-04-15
Q3 2022 -$186M -$21M +$24.3M +53.7% Jun 1, 2022 Aug 31, 2022 10-Q 2024-04-15
Q2 2022 -$211M -$84.1M -$14M -20% Mar 1, 2022 May 31, 2022 10-K 2023-09-14
Q1 2022 -$197M -$41.3M -$3.7M -9.86% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-10
Q4 2021 -$193M -$40.1M -$2.1M -5.52% Sep 1, 2021 Nov 30, 2021 10-Q 2023-04-10
Q3 2021 -$191M -$45.3M -$14.5M -47% Jun 1, 2021 Aug 31, 2021 10-Q 2023-04-10
Q2 2021 -$176M -$70.1M +$3.07M +4.2% Mar 1, 2021 May 31, 2021 10-K 2022-08-15
Q1 2021 -$180M -$37.6M -$1.81M -5.07% Dec 1, 2020 Feb 28, 2021 10-K 2022-08-15
Q4 2020 -$178M -$38M -$23.1M -156% Sep 1, 2020 Nov 30, 2020 10-K 2022-08-15
Q3 2020 -$155M -$30.8M -$14.7M -90.7% Jun 1, 2020 Aug 31, 2020 10-Q 2022-04-11
Q2 2020 -$140M -$73.1M -$53.7M -277% Mar 1, 2020 May 31, 2020 10-K 2022-08-15
Q1 2020 -$86.2M -$35.8M -$23.2M -184% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 -$63M -$14.9M -$555K -3.88% Sep 1, 2019 Nov 30, 2019 10-Q 2021-04-14
Q3 2019 -$62.5M -$16.2M -$1.75M -12.1% Jun 1, 2019 Aug 31, 2019 10-Q 2021-04-14
Q2 2019 -$60.7M -$19.4M -$9.8M -102% Mar 1, 2019 May 31, 2019 10-Q 2022-01-10
Q1 2019 -$50.9M -$12.6M +$5.38M +30% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-09
Q4 2018 -$56.3M -$14.3M -$3.36M -30.7% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q3 2018 -$52.9M -$14.4M -$2.79M -24% Jun 1, 2018 Aug 31, 2018 10-Q 2020-01-09
Q2 2018 -$50.1M -$9.62M -$2.79M -40.9% Mar 1, 2018 May 31, 2018 10-Q 2019-01-09
Q1 2018 -$47.4M -$18M -$9.84M -121% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-09
Q4 2017 -$37.5M -$10.9M -$5.68M -108% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-09
Q3 2017 -$31.8M -$11.6M -$2.73M -30.7% Jun 1, 2017 Aug 31, 2017 10-Q 2019-01-09
Q2 2017 -$29.1M -$6.83M -$332K -5.12% Mar 1, 2017 May 31, 2017 10-K 2018-07-27
Q1 2017 -$28.8M -$8.11M -$3.07M -60.7% Dec 1, 2016 Feb 28, 2017 10-K 2018-07-27
Q4 2016 -$25.7M -$5.26M $0 0% Sep 1, 2016 Nov 30, 2016 10-K 2018-07-27
Q3 2016 -$25.7M -$8.9M $0 0% Jun 1, 2016 Aug 31, 2016 10-K 2018-07-27
Q2 2016 -$25.7M -$6.5M +$7.51M +53.6% Feb 29, 2016 May 31, 2016 10-K 2018-07-27
Q1 2016 -$33.2M -$5.05M -$2.33M -85.4% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-13
Q4 2015 -$30.9M -$5.26M -$281K -5.63% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-13
Q3 2015 -$30.6M -$8.9M -$5.52M -163% Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-12
Q2 2015 -$25.1M -$14M -$11M -367% Mar 1, 2015 May 31, 2015 10-K 2016-07-19
Q1 2015 -$14.1M -$2.72M +$553K +16.9% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-13
Q4 2014 -$14.6M -$4.98M -$1.4M -38.9% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-11
Q3 2014 -$13.2M -$3.38M -$806K -31.3% Jun 1, 2014 Aug 31, 2014 10-Q 2015-10-09
Q2 2014 -$12.4M -$3M -$510K -20.5% Mar 1, 2014 May 31, 2014 10-K 2015-07-10
Q1 2014 -$11.9M -$3.27M -$915K -38.8% Dec 1, 2013 Feb 28, 2014 10-Q 2015-04-10
Q4 2013 -$11M -$3.59M -$1.68M -88% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-12
Q3 2013 -$9.33M -$2.57M +$242K +8.58% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-10
Q2 2013 -$9.57M -$2.49M +$907K +26.7% Mar 1, 2013 May 31, 2013 10-K 2014-07-10
Q1 2013 -$10.5M -$2.36M -$941K -66.4% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-11
Q4 2012 -$9.53M -$1.91M -$411K -27.5% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q3 2012 -$9.12M -$2.82M -$1.65M -141% Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-15
Q2 2012 -$7.47M -$3.39M -$2.29M -207% Mar 1, 2012 May 31, 2012 10-K 2013-08-29
Q1 2012 -$5.19M -$1.42M -$342K -31.8% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-12
Q4 2011 -$4.85M -$1.5M -$507K -51.3% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q3 2011 -$4.34M -$1.17M -$619K -113% Jun 1, 2011 Aug 31, 2011 10-Q/A 2012-11-08
Q2 2011 -$3.72M -$1.11M Mar 1, 2011 May 31, 2011 10-K 2013-08-29
Q1 2011 -$1.08M Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-16
Q4 2010 -$990K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-17
Q3 2010 -$548K Jun 1, 2010 Aug 31, 2010 10-Q/A 2011-11-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.